Page last updated: 2024-10-25
dapsone and Apoplexy
dapsone has been researched along with Apoplexy in 2 studies
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Dapsone appears as a useful and safe drug for the treatment of stroke patients." | 9.12 | Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study. ( Calzada, P; Góngora-Rivera, F; Nader-Kawachi, J; Ríos, C; Santos-Zambrano, J, 2007) |
" We have shown that dapsone acts as an antioxidant, antiinflammatory and antiapoptotic agent after brain Ischemia reperfusion (I/R) in rats; however, its therapeutic efficacy, measured by imaging has not been characterized." | 7.83 | Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. ( Diaz-Ruiz, A; Heras-Romero, Y; Mendez-Armenta, M; Mondragón-Lozano, R; Nava-Ruiz, C; Ortiz-Plata, A; Osorio-Rico, L; Ríos, C; Roldan-Valadez, E, 2016) |
"Dapsone appears as a useful and safe drug for the treatment of stroke patients." | 5.12 | Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study. ( Calzada, P; Góngora-Rivera, F; Nader-Kawachi, J; Ríos, C; Santos-Zambrano, J, 2007) |
" We have shown that dapsone acts as an antioxidant, antiinflammatory and antiapoptotic agent after brain Ischemia reperfusion (I/R) in rats; however, its therapeutic efficacy, measured by imaging has not been characterized." | 3.83 | Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. ( Diaz-Ruiz, A; Heras-Romero, Y; Mendez-Armenta, M; Mondragón-Lozano, R; Nava-Ruiz, C; Ortiz-Plata, A; Osorio-Rico, L; Ríos, C; Roldan-Valadez, E, 2016) |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Diaz-Ruiz, A | 1 |
Roldan-Valadez, E | 1 |
Ortiz-Plata, A | 1 |
Mondragón-Lozano, R | 1 |
Heras-Romero, Y | 1 |
Mendez-Armenta, M | 1 |
Osorio-Rico, L | 1 |
Nava-Ruiz, C | 1 |
Ríos, C | 2 |
Nader-Kawachi, J | 1 |
Góngora-Rivera, F | 1 |
Santos-Zambrano, J | 1 |
Calzada, P | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Trial Randomized, Placebo-controlled, Using Dapsone as a Neuroprotector During Acute Ischemia Stroke[NCT01144650] | Phase 2/Phase 3 | 300 participants (Anticipated) | Interventional | 2009-07-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for dapsone and Apoplexy
Article | Year |
---|---|
Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Dapsone; Dose-Response Relationship, Drug; Double-Blind Method; Fema | 2007 |
Other Studies
1 other study available for dapsone and Apoplexy
Article | Year |
---|---|
Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats.
Topics: Animals; Brain; Brain Ischemia; Dapsone; Magnetic Resonance Imaging; Male; Neuroprotective Agents; N | 2016 |